Search Results for: Roche
Belharra Therapeutics Exits Stealth With $130 Million And A Genentech Deal
2023-01-05
Acer Snags First-Ever FDA Approval With Relief-Partnered Olpruva
2022-12-28
Roche’s Lunsumio Lands FDA Approval for Pretreated Follicular Lymphoma
2022-12-26
Pfizer Begins Phase 2 Of Diabetes Drug, Triggering $10 Million Milestone To Sosei Heptares
2022-12-22
Biogen To Receive Potential Royalties For Anti-CD20 Bispecific From Genentech
2022-12-20
A Force To Be Reckoned With – BioBetter Biologics
2022-12-14
Using Sound Waves to Sort Blood-Based Nanoparticles
2022-12-07
Axsome’s AXS-05 Achieves Endpoints In Alzheimer’s Agitation Trial
2022-11-29
Canada Authorizes Roche’s Polivy as First-Line Lymphoma Treatment
2022-11-27
ImmunoGen Wins FDA Accelerated Approval For Ovarian Cancer Drug
2022-11-16
Roche’s Gantenerumab Fails Trials In Alzheimer’s Disease
2022-11-15
CDC Warns Of “Tripledemic” Winter Amid Rising Flu And RSV Cases
2022-11-14
AbbVie and Genmab’s Joint Cancer Treatment Receives EMA Validation
2022-10-28
Roche Clocks Clinical Win as it Eyes Additional Vabysmo Indication
2022-10-27
ImmVira announced its signing of Series C+ financing and negotiation with further investors for the round
2022-10-26
1 2 3 4 5 20
Scroll to Top